Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.03 | 19.82 |
| PEG Ratio (TTM) | 0.00 | 15.95 |
| P/S Ratio (TTM) | 0.32 | 2.40 |
| P/B Ratio (TTM) | 0.03 | 5.34 |
| P/FCF Ratio (TTM) | -0.60 | 24.07 |
| Price to 5YR AVG Earnings Ratio | N/A | 25.86 |
| Price to 5YR AVG FCF Ratio | N/A | 18.55 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -89.18% | 6.84% |
| ROE (TTM) | -105.34% | 21.05% |
| Net Profit Margin (TTM) | -141.96% | 9.80% |
| ROIC 5YR AVG | N/A | -38.24% |
Growth (5%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -221.42% | -18.91% | N/A |
| Revenue | 3.85% | -8.91% | N/A |
| Net Income | -108.53% | -96.26% | N/A |
| Cash Flow | -28.95% | -470.52% | N/A |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.73 | 1.88 |
| Quick Ratio (TTM) | 3.29 | 1.41 |
| D/E Ratio (TTM) | N/A | 2.08 |
| Interest Coverage (TTM) | -54.54 | 11.58 |
| Piotroski F-Score | 3 | 6 |
| Altman Z-Score | N/A | 4.33 |
| LTL to 5YR AVG FCF | N/A | 1.28 |
| Shares Outstanding Growth 5YR AVG | N/A | 3.78% |